Hepatopulmonary Syndrome clinical trials at UCSF
1 research study open to eligible people
open to eligible people ages 18-99
The purpose of this study is to assess the safety, tolerability and possible benefit of letrozole compared to placebo in patients with Hepatopulmonary Syndrome.
San Francisco, California and other locations